全球温控药品容器市场

到2030年，全球温控药品包装市场规模将达88亿美元

全球温控药品容器市场规模在 2024 年估计为 49 亿美元，预计到 2030 年将达到 88 亿美元，2024 年至 2030 年的复合年增长率为 10.1%。绝缘运输箱是报告中分析的细分市场之一，预计复合年增长率为 11.6%，到分析期结束时达到 52 亿美元。在分析期内，保温容器部分预计将以 8.0% 的复合年增长率成长。

美国市场规模估计为 13 亿美元，中国市场预计复合年增长率为 14.0%

预计到 2024 年，美国温控药品容器市场价值将达到 13 亿美元。作为世界第二大经济体的中国，预计到 2030 年市场规模将达到 18 亿美元，在 2024-2030 年分析期内的复合年增长率为 14.0%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为 7.1% 和 9.0%。在欧洲，预计德国的复合年增长率约为 8.0%。

全球温控药品容器市场－主要趋势与驱动因素摘要

为什么温控容器对于医药供应链的完整性和病人安全至关重要？

温控药品容器对于维持热敏性药物、生技药品和疫苗在储存和运输过程中的稳定性、有效性和安全性至关重要。许多药物，包括胰岛素、单株抗体、基因疗法药物和 COVID-19 疫苗，都需要严格的温度范围（例如 2-8°C、-20°C、-70°C）来维持其化学成分和治疗价值。偏离有效的储存条件可能导致产品劣化、不符合法规和严重的临床后果。

这些货柜提供了有效的低温运输解决方案，降低了远距运输、跨境物流和最后一英里交付相关的风险。这些容器整合了隔热材料、相变材料 (PCM)、真空面板以及某些情况下的主动冷却装置，可确保在不同的气候和基础设施环境中不间断地控制温度。随着医药供应链日益全球化以及监管审查力度加大，这些容器在确保产品安全合规分销方面发挥关键作用。

技术创新和数位监控如何提高货柜效率和合规性？

材料和设计技术的进步正在扩展温控容器的功能。新一代被动容器采用先进的隔热材料和高效能 PCM 技术，无需外部电源即可长时间（通常长达 120 小时）保持温度。同时，配备电池供电压缩机和热电系统的主动货柜能够实现精确的温度控制和对环境波动的动态响应，使其成为超低温链要求的理想选择。

数位化整合也正在重塑这个类别。货柜系统现已内建即时温度记录、GPS 追踪、湿度监测和衝击/振动感测器，可实现端到端可视性和法规遵循文件。云端基础的仪表板和自动警报使相关人员能够远端监控产品状态，从而提高风险缓解和审核准备。这种智慧包装系统越来越被视为高价值、高风险医药产品运输的必需品，特别是在临床试验物流和专业药品分销方面。

哪些治疗领域和供应链场景推动了容器的应用？

生技药品、疫苗、细胞和基因疗法等先进疗法对温度变化极为敏感，因此对温控药品容器的需求最高。个人化医疗和特种药品的兴起，往往需要从製造到床边管理的低温运输物流，这推动了对检验、温度保证的运输的需求。季节性疫苗接种计划、疫情应对工作和不断扩大的疫苗宣传活动正在推动容器利用率的提高。

同时，临床试验供应链，特别是涉及分散临床试验和国际临床实验网路的临床试验供应链，越来越依赖专门的低温运输包装来维持样本和临床实验产品的可行性。人道援助物流、温度敏感诊断剂和抗癌药物分发是其他快速扩展的使用案例。这些多样化的应用反映了医药物流领域更广泛的转型，其中温控包装正在成为一种战略要务，而不是一种营运增值。

监管标准、永续性目标和成本压力如何影响市场动态？

遵守良好分销规范 (GDP)、USP <1079> 和国际航空运输协会易腐货物规定等国际法规结构决定了温控货柜领域的产品设计和文件标准。製药公司面临着证明整个分销链中始终保持一致的储存条件的压力，这增加了对具有资料登录、资格证书和路线检验支援的容器的需求。

永续性和成本效益已成为双重挑战。製造商正在探索可重复使用的容器模型、可回收的隔热材料和低碳被动冷却技术，以减少对环境的影响。同时，医药经销商也寻求优化载重比、标准化货柜格式，以降低运输成本、提高物流效率。随着越来越多的生技药品进入研发管线，供应链在全球扩张，成本控制和合规性之间的紧张关係正在决定该领域的采购和创新策略。

推动温控药品容器市场成长的因素有哪些？

受医药供应链日益复杂、温敏生生技药品的普及以及全球对法规遵从性和患者安全的日益关注的推动，温控医药容器市场正在迅速扩张。随着低温运输基础设施对医疗保健服务变得越来越重要，製造商、物流供应商和医疗机构对先进、高效的货柜系统的投资正在加速。

未来的市场成长将取决于供应商如何有效平衡精确度、成本效益、永续性和数位可追溯性。温控容器是否能够发展以满足下一代疗法、日益分散的医疗保健模式和全球化分销网络的需求，将决定其在未来医药低温运输中的战略作用。

部分

产品类型（绝缘托运人、绝缘容器、其他产品类型）、控制类型（主动、被动）、应用（冷冻、冷藏、常温）、最终用户（生物製药公司、研究机构、其他最终用户）

受访企业范例（共43家）

• ACH Foam Technologies
• AmerisourceBergen Corporation
• Cold Chain Technologies
• Cryopak Industries Inc.
• CSafe Global
• DHL International GmbH
• DGP Intelsius
• Envirotainer AB
• Exeltainer SL
• FedEx Corporation
• Inmark Global Holdings LLC
• OMEGA Engineering
• Olympus Corporation
• Pelican BioThermal
• Saeplast
• Snyder Industries
• Softbox Systems
• Sofrigam SA
• Sonoco ThermoSafe
• va-Q-tec AG

关税影响係数

全球产业分析师根据公司总部所在国家、製造地以及进出口（成品和OEM）预测公司竞争地位的变化。这种复杂且多方面的市场动态预计将以多种方式影响竞争对手，包括人为提高销货成本、降低盈利、重组供应链等微观和宏观市场动态。

全球产业分析师密切关注世界领先的首席经济学家（14,949）、智库（62）和贸易及产业协会（171）的专家意见，以评估生态系统的影响并应对新的市场现实。各主要国家的专家和经济学家都在关注关税及其对国家的影响。

全球产业分析师预计，这种动盪将在未来几个月内平息，新的世界秩序将更加明确地建立。全球产业分析师正在即时追踪这些发展。

2025年4月：谈判阶段

我们四月份的发布将涵盖关税对全球市场整体的影响，并为各地区的市场调整提供指导。我们的预测是基于历史数据和不断发展的市场影响因素。

2025年7月：最终关税调整

免费更新 在各国宣布最终重置后，本公司的客户将在 7 月收到免费更新。最终更新包含明确的关税影响分析。

相互和双边贸易及关税影响分析：

美国<>中国<>墨西哥<>加拿大<>欧盟<>日本<>印度<>其他176个国家

领先的产业经济学家：全球产业分析师知识库追踪 14,949 位经济学家，其中包括来自民族国家、智库、贸易和产业协会、大型企业和领域专家的最具影响力的首席经济学家，他们共用了全球经济状况这一前所未有的模式转移的影响。我们的 16,491 多份报告中的大多数都遵循这个基于两阶段里程碑的发布计划。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 竞赛

Global Temperature Controlled Pharmaceutical Containers Market to Reach US$8.8 Billion by 2030

The global market for Temperature Controlled Pharmaceutical Containers estimated at US$4.9 Billion in the year 2024, is expected to reach US$8.8 Billion by 2030, growing at a CAGR of 10.1% over the analysis period 2024-2030. Insulated Shippers, one of the segments analyzed in the report, is expected to record a 11.6% CAGR and reach US$5.2 Billion by the end of the analysis period. Growth in the Insulated Containers segment is estimated at 8.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.3 Billion While China is Forecast to Grow at 14.0% CAGR

The Temperature Controlled Pharmaceutical Containers market in the U.S. is estimated at US$1.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.8 Billion by the year 2030 trailing a CAGR of 14.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.1% and 9.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.0% CAGR.

Global Temperature Controlled Pharmaceutical Containers Market - Key Trends & Drivers Summarized

Why Are Temperature Controlled Containers Critical to Pharmaceutical Supply Chain Integrity and Patient Safety?

Temperature controlled pharmaceutical containers are indispensable in maintaining the stability, efficacy, and safety of temperature-sensitive drugs, biologics, and vaccines during storage and transportation. Many pharmaceutical products-including insulin, monoclonal antibodies, gene therapies, and COVID-19 vaccines-require strict temperature ranges (e.g., 2-8°C, -20°C, or -70°C) to preserve chemical composition and therapeutic value. Deviations from validated storage conditions can lead to product degradation, regulatory non-compliance, and severe clinical consequences.

These containers provide a validated cold chain solution, mitigating risks associated with long-distance shipping, cross-border logistics, and last-mile delivery. Integrated with thermal insulation, phase-change materials (PCMs), vacuum panels, and sometimes active refrigeration units, they ensure uninterrupted temperature control across diverse climatic and infrastructure environments. As pharmaceutical supply chains globalize and regulatory scrutiny intensifies, these containers serve as critical enablers of secure and compliant product distribution.

How Are Innovation and Digital Monitoring Enhancing Container Efficiency and Compliance?

Technological advancements in materials and design are expanding the capabilities of temperature controlled containers. New-generation passive containers use advanced insulation and high-performance PCMs to maintain temperature for extended durations-often up to 120 hours-without requiring external power. Meanwhile, active containers equipped with battery-powered compressors or thermoelectric systems enable precise temperature control and dynamic response to environmental fluctuations, ideal for ultra-cold chain requirements.

Digital integration is also reshaping the category. Real-time temperature logging, GPS tracking, humidity monitoring, and shock/vibration sensors are now embedded into container systems, enabling end-to-end visibility and documentation for regulatory compliance. Cloud-based dashboards and automated alerts allow stakeholders to monitor product condition remotely, enhancing risk mitigation and audit readiness. These smart packaging systems are increasingly seen as essential for high-value, high-risk pharmaceutical shipments, particularly in clinical trial logistics and specialty medicine distribution.

Which Therapeutic Segments and Supply Chain Scenarios Are Driving Container Adoption?

Biologics, vaccines, and advanced therapies such as cell and gene therapies are driving the highest demand for temperature controlled pharmaceutical containers due to their extreme sensitivity to thermal variation. The rise of personalized medicine and specialty drugs, which often require cold chain logistics from manufacturing to bedside administration, has intensified the need for validated, temperature-assured transport. Seasonal vaccine programs, pandemic response efforts, and expanded immunization campaigns continue to elevate container utilization.

In parallel, clinical trial supply chains-particularly those involving decentralized trials and international site networks-are increasingly reliant on specialized cold chain packaging to maintain sample and investigational product viability. Humanitarian aid logistics, temperature-sensitive diagnostic reagents, and oncology drug distribution also represent fast-growing use cases. These varied applications reflect a broader transformation in pharmaceutical logistics, where temperature-controlled packaging has become a strategic imperative rather than an operational add-on.

How Are Regulatory Standards, Sustainability Goals, and Cost Pressures Influencing Market Dynamics?

Compliance with international regulatory frameworks such as Good Distribution Practice (GDP), USP <1079>, and IATA Perishable Goods Regulations is shaping product design and documentation standards across the temperature controlled container segment. Pharmaceutical companies are under pressure to demonstrate that storage conditions were consistently maintained throughout the distribution chain, prompting demand for containers with data logging, qualification certificates, and route validation support.

Sustainability and cost-efficiency are emerging as dual imperatives. Manufacturers are exploring reusable container models, recyclable insulation materials, and lower-carbon passive cooling technologies to reduce environmental impact. At the same time, pharmaceutical distributors are seeking optimized payload-to-weight ratios and standardized container formats to cut freight costs and improve logistics efficiency. As more biologics enter the pipeline and supply chains stretch globally, the tension between cost containment and compliance readiness is defining procurement and innovation strategies in this space.

What Are the Factors Driving Growth in the Temperature Controlled Pharmaceutical Containers Market?

The temperature controlled pharmaceutical containers market is expanding rapidly, propelled by the growing complexity of pharmaceutical supply chains, the proliferation of temperature-sensitive biologics, and the rising global focus on regulatory compliance and patient safety. As cold chain infrastructure becomes integral to healthcare delivery, investments in advanced, validated container systems are accelerating across manufacturers, logistics providers, and healthcare institutions.

Looking ahead, market growth will hinge on how effectively suppliers can balance precision, cost-efficiency, sustainability, and digital traceability. Whether temperature controlled containers can evolve to meet the needs of next-generation therapies, increasingly decentralized care models, and globalized distribution networks will define their strategic role in the pharmaceutical cold chain of the future.

SCOPE OF STUDY:

The report analyzes the Temperature Controlled Pharmaceutical Containers market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Insulated Shippers, Insulated Containers, Other Product Types); Control Type (Active, Passive); Application (Frozen, Chilled, Ambient); End-User (Biopharmaceutical Companies, Research Institutes, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

• ACH Foam Technologies
• AmerisourceBergen Corporation
• Cold Chain Technologies
• Cryopak Industries Inc.
• CSafe Global
• DHL International GmbH
• DGP Intelsius
• Envirotainer AB
• Exeltainer SL
• FedEx Corporation
• Inmark Global Holdings LLC
• OMEGA Engineering
• Olympus Corporation
• Pelican BioThermal
• Saeplast
• Snyder Industries
• Softbox Systems
• Sofrigam SA
• Sonoco ThermoSafe
• va-Q-tec AG

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Temperature Controlled Pharmaceutical Containers - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Vaccine Logistics and Biologics Supply Chains Drive High-Performance Temperature Controlled Container Demand
  • GDP Compliance and Cold Chain Integrity Requirements Reinforce Role of Passive and Active Transport Solutions
  • IoT and Data Logger Integration Supports Real-Time Temperature, Location, and Shock Monitoring
  • Reusable Container Programs Expand Among Major Distributors to Reduce Packaging Waste and Costs
  • Regional Distribution Expansion in LMICs Spurs Demand for Affordable, Portable Insulated Solutions
  • Smart RFID Tags and Blockchain-Enabled Audit Trails Improve Traceability and Compliance
  • Demand Rises for Last-Mile Controlled Containers for Home Delivery and DTP Models
  • Biologics, Gene Therapies, and Cell Therapies Push Innovation in Ultra-Cold Shipping Technologies
  • Modular Container Designs Support Multi-Route Deployment and Air, Land, Sea Compatibility
  • Emergency Response and Humanitarian Aid Programs Drive Portable Cold Chain Equipment Uptake
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Temperature Controlled Pharmaceutical Containers Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Temperature Controlled Pharmaceutical Containers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Insulated Shippers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Insulated Shippers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Insulated Shippers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Insulated Containers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Insulated Containers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Insulated Containers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Biopharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Active by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Active by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Active by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Passive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Passive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Passive by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Frozen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Frozen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Frozen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Chilled by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Chilled by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Chilled by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Ambient by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Ambient by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Ambient by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Temperature Controlled Pharmaceutical Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 38: USA Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• JAPAN
  • Temperature Controlled Pharmaceutical Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Japan 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• CHINA
  • Temperature Controlled Pharmaceutical Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 74: China Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 80: China Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: China 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 83: China Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: China Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: China 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• EUROPE
  • Temperature Controlled Pharmaceutical Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Temperature Controlled Pharmaceutical Containers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Europe 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 95: Europe Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Europe 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 98: Europe Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Europe Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Europe 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• FRANCE
  • Temperature Controlled Pharmaceutical Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 101: France Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: France Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: France 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 104: France Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: France Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: France 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 107: France Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: France Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: France 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 110: France Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: France Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: France 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• GERMANY
  • Temperature Controlled Pharmaceutical Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 113: Germany Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Germany Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Germany 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 116: Germany Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Germany Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Germany 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 119: Germany Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Germany Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Germany 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 122: Germany Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Germany Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Germany 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 125: Italy Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Italy Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Italy 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 128: Italy Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Italy Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Italy 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 131: Italy Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Italy Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Italy 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 134: Italy Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Italy Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Italy 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Temperature Controlled Pharmaceutical Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 137: UK Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: UK Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: UK 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 140: UK Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: UK Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: UK 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 143: UK Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: UK Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: UK 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 146: UK Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: UK Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: UK 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 149: Spain Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Spain Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Spain 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 152: Spain Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Spain Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Spain 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 155: Spain Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Spain Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Spain 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 158: Spain Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Spain Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Spain 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 161: Russia Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Russia Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Russia 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 164: Russia Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Russia Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Russia 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 167: Russia Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Russia Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Russia 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 170: Russia Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Russia Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Russia 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 173: Rest of Europe Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Rest of Europe Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Rest of Europe 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Rest of Europe Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Rest of Europe 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Europe Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Rest of Europe 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Europe Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Europe 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Temperature Controlled Pharmaceutical Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 185: Asia-Pacific Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 186: Asia-Pacific Historic Review for Temperature Controlled Pharmaceutical Containers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Asia-Pacific 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Asia-Pacific Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Asia-Pacific 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Asia-Pacific Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Asia-Pacific 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Asia-Pacific Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Asia-Pacific 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Asia-Pacific Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Asia-Pacific 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Temperature Controlled Pharmaceutical Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 200: Australia Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Australia Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Australia 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 203: Australia Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Australia Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Australia 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 206: Australia Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Australia Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Australia 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 209: Australia Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Australia Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Australia 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• INDIA
  • Temperature Controlled Pharmaceutical Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 212: India Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: India Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: India 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 215: India Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: India Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: India 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 218: India Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: India Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: India 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 221: India Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: India Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: India 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 224: South Korea Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: South Korea Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: South Korea 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 227: South Korea Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: South Korea Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: South Korea 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 230: South Korea Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: South Korea Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: South Korea 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 233: South Korea Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: South Korea Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: South Korea 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 236: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Asia-Pacific Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Asia-Pacific 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Asia-Pacific Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Asia-Pacific 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Asia-Pacific Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Asia-Pacific Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Asia-Pacific 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Temperature Controlled Pharmaceutical Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 248: Latin America Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 249: Latin America Historic Review for Temperature Controlled Pharmaceutical Containers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Latin America 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 251: Latin America Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Latin America Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Latin America 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 254: Latin America Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Latin America Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Latin America 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 257: Latin America Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Latin America Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Latin America 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 260: Latin America Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Latin America Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Latin America 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 263: Argentina Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Argentina Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Argentina 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 266: Argentina Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Argentina Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Argentina 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 269: Argentina Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Argentina Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Argentina 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 272: Argentina Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Argentina Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Argentina 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 275: Brazil Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Brazil Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Brazil 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 278: Brazil Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Brazil Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Brazil 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 281: Brazil Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Brazil Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Brazil 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 284: Brazil Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Brazil Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Brazil 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 287: Mexico Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Mexico Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Mexico 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 290: Mexico Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Mexico Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Mexico 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 293: Mexico Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Mexico Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Mexico 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 296: Mexico Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Mexico Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Mexico 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 299: Rest of Latin America Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Latin America Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Latin America 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Latin America Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Latin America 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Latin America Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Latin America 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Latin America Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Latin America 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Temperature Controlled Pharmaceutical Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 311: Middle East Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 312: Middle East Historic Review for Temperature Controlled Pharmaceutical Containers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Middle East 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 314: Middle East Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Middle East Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Middle East 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 317: Middle East Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Middle East Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: Middle East 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 320: Middle East Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Middle East Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 322: Middle East 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 323: Middle East Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Middle East Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 325: Middle East 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 326: Iran Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Iran Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 328: Iran 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 329: Iran Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Iran Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 331: Iran 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 332: Iran Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Iran Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 334: Iran 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 335: Iran Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Iran Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 337: Iran 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 338: Israel Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Israel Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 340: Israel 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 341: Israel Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Israel Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 343: Israel 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 344: Israel Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Israel Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 346: Israel 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 347: Israel Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Israel Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 349: Israel 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 350: Saudi Arabia Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Saudi Arabia Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 352: Saudi Arabia 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Saudi Arabia Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 355: Saudi Arabia 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Saudi Arabia Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 358: Saudi Arabia 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Saudi Arabia Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 361: Saudi Arabia 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 362: UAE Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: UAE Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 364: UAE 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 365: UAE Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: UAE Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 367: UAE 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 368: UAE Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: UAE Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 370: UAE 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 371: UAE Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: UAE Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 373: UAE 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 374: Rest of Middle East Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: Rest of Middle East Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 376: Rest of Middle East 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Rest of Middle East Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 379: Rest of Middle East 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Rest of Middle East Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 382: Rest of Middle East 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Rest of Middle East Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 385: Rest of Middle East 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• AFRICA
  • Temperature Controlled Pharmaceutical Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 386: Africa Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Africa Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 388: Africa 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 389: Africa Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Africa Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 391: Africa 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 392: Africa Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Africa Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 394: Africa 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 395: Africa Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Africa Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 397: Africa 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030

IV. COMPETITION